(Q77227878)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10192361%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

title

Fractionation and protraction for radiotherapy of prostate carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10192361%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1 reference

D J Brenner

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10192361%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

E J Hall

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10192361%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

language of work or name

English

0 references

publication date

1 March 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10192361%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Radiation Oncology Biology Physics

3 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10192361%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10192361%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

page(s)

1095-1101

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10192361%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10192361%20AND%20SRC:MED&resulttype=core&format=json

Three-dimensional conformal radiotherapy and dose escalation: where do we stand?

3 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900438-6

7 January 2021

Current issues in techniques of prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900438-6

7 January 2021

Radiotherapy for high grade clinically localized adenocarcinoma of the prostate.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900438-6

7 January 2021

External beam radiotherapy dose response of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900438-6

7 January 2021

Optimization of conformal radiation treatment of prostate cancer: Report of a dose escalation study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900438-6

7 January 2021

A dose-response study for I-125 prostate implants

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900438-6

7 January 2021

How well is the probability of tumor cure after fractionated irradiation described by Poisson statistics?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900438-6

7 January 2021

The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900438-6

7 January 2021

Fractionated high dose-rate versus low dose-rate regimens for intracavitary brachytherapy of the cervix: equivalent regimens for combined brachytherapy and external irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900438-6

7 January 2021

Isoeffect models and fractionated radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900438-6

7 January 2021

A rationale for fractionation for slowly proliferating tumors such as prostatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900438-6

7 January 2021

Cell kinetic measurements in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900438-6

7 January 2021

Serum prostate-specific antigen profile following radiotherapy for prostate cancer: implications for patterns of failure and definition of cure

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900438-6

7 January 2021

Prostate specific antigen doubling time and disease relapse after radiotherapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900438-6

7 January 2021

Radiobiological assessment of permanent implants using tumour repopulation factors in the linear-quadratic model.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900438-6

7 January 2021

The effect of overall treatment time on the outcome of definitive radiotherapy for localized prostate carcinoma: the Radiation Therapy Oncology Group 75-06 and 77-06 experience

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900438-6

7 January 2021

Dose, volume, and tumor-control predictions in radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900438-6

7 January 2021

Prostate specific antigen and gleason grade: an immunohistochemical study of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900438-6

7 January 2021

Serum prostate-specific antigen and the biologic progression of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900438-6

7 January 2021

Time-dose factors in radiotherapy: a review of the human data.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900438-6

7 January 2021

Clinical radiobiology of malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900438-6

7 January 2021

Tumor radioresponsiveness versus fractionation sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900438-6

7 January 2021

The relationship between tumor oxygenation and cell proliferation in human soft tissue sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900438-6

7 January 2021

Cell kinetics by bromodeoxyuridine labeling and deoxyribonucleic acid ploidy in prostatic carcinoma needle biopsies

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900438-6

7 January 2021

The relevance of alpha/beta ratios determined in vitro for human cell lines to the understanding of in vivo values

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900438-6

7 January 2021

Radiation response of xenografts of a human squamous cell carcinoma and a glioblastoma multiforme: a progress report.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900438-6

7 January 2021

Differential response of rapidly- and slowly-proliferating hair follicles of mice to fractionated irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900438-6

7 January 2021

Direct Analyses ofin VivoColony Survival after Single and Fractionated Doses of Radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900438-6

7 January 2021

Radical external beam radiotherapy for localised carcinoma of the prostate using a hypofractionation technique

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900438-6

7 January 2021

Some methodological problems in estimating radiobiological parameters from clinical data. Alpha/beta ratios and electron RBE for cutaneous reactions in patients treated with postmastectomy radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900438-6

7 January 2021

Letter: The NSD concept and radioresistant tumours.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900438-6

7 January 2021

The relationship between total dose, number of fractions and fractions size in the response of malignant melanoma in patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900438-6

7 January 2021

Hyperfractionated conformal radiotherapy in locally advanced prostate cancer: results of a dose escalation study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900438-6

7 January 2021

Ultrasound-guided high dose rate conformal brachytherapy boost in prostate cancer: treatment description and preliminary results of a phase I/II clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900438-6

7 January 2021

10.1016/S0360-3016(98)00438-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10192361%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1 reference